# Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

> **NCT03905538** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** [18F]FLT-PET/CT

## Key facts

- **NCT ID:** NCT03905538
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08-13
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03905538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03905538, "Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03905538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*